Comparison of low mulecular weight heparin and unfractionated heparin in cerebral venouse thrombosis treatment
Phase 2
- Conditions
- cerebral venouse sinus thrombosis.Other vascular syndromes of brain in cerebrovascular diseases
- Registration Number
- IRCT201102241856N3
- Lead Sponsor
- Vice-chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Inclusion criterion: the patients with cerebral venouse thrombosis diagnosed on the basis of MR venography. Exclusion criteria: age of <18 years old; contraindications for anticoagulant; bleeding disorder; hepatic or renal dysfunction; uncontrolled hypertension; thrombocytopenia; gastrointestinal hemorrhage; papilledema with impaired vision that required lumbar punctures.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measure of global disability. Timepoint: before of the trearment,discharge time,one month after discharge. Method of measurement: according to modified Rankin scale.
- Secondary Outcome Measures
Name Time Method Focal neurologic deficit. Timepoint: before of treatment,discharge time,one month after discharge. Method of measurement: NIH Stroke scale.